Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

AVBP

ArriVent BioPharma, Inc.

CIK 0001868279 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$29.12
↓ 0.06 (-0.21%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.44B
P/E Ratio
-8.77
EPS
-4.32
Dividend Yield
Not covered
52W Position
64%
Beta
1.18

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.91
P/S
Not covered
EV/Revenue
Not covered
ROE
-44.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 64%
$17.00$35.83

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$166.31M
Total Assets
$333.17M
Free Cash Flow
–

Recent news